BPMC

Blueprint Medicines
BPMC

Overview Fund Activity
Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

134 hedge funds and large institutions have $1.39B invested in Blueprint Medicines in 2017 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 50 increasing their positions, 27 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
134
Holders Change
+31
Holders Change %
+30.1%
% of All Funds
3.34%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.22%
New
45
Increased
50
Reduced
27
Closed
9
Calls
$2.84M
Puts
$1.94M
Net Calls
+$903K
Net Calls Change
+$1.42M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$153M
2
BlackRock
2
BlackRock
New York
$82.1M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$80.6M
4
AllianceBernstein
4
AllianceBernstein
Tennessee
$38.9M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$191M

Top Sellers

1
BI
1
BVF Inc
California
$84.1M
2
DM
2
Deerfield Management
New York
$54.6M
3
CAM
3
Cormorant Asset Management
Massachusetts
$24M
4
SH
4
Sandia Holdings
Connecticut
$19.7M
5
DCM
5
Driehaus Capital Management
Illinois
$35.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
EAM
26
Eventide Asset Management
Massachusetts
$10.6M – – –
FCMI
27
Foresite Capital Management III
California
$10.4M -$1.58M -39,600 -13%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$10.2M +$1.04M +26,128 +11%
Franklin Resources
29
Franklin Resources
California
$8M – – –
MIM
30
Monashee Investment Management
Massachusetts
$7M -$2.24M -80,000 Closed
CCM
31
Cadian Capital Management
New York
$6.99M +$6.99M +174,900 New
Fidelity International
32
Fidelity International
Bermuda
$6.9M -$3.38M -84,500 -33%
Citadel Advisors
33
Citadel Advisors
Florida
$6.86M +$3.87M +96,863 +130%
ACA
34
Avoro Capital Advisors
New York
$6.6M +$6.6M +165,000 New
Jennison Associates
35
Jennison Associates
New York
$6M +$6M +150,000 New
Two Sigma Investments
36
Two Sigma Investments
New York
$5.92M +$5.92M +148,105 New
JPMorgan Chase & Co
37
JPMorgan Chase & Co
New York
$5.79M -$887K -22,168 -13%
PC
38
PointState Capital
New York
$5.18M +$5.18M +129,500 New
GPP
39
Great Point Partners
Connecticut
$4.88M +$4.88M +122,129 New
Bank of New York Mellon
40
Bank of New York Mellon
New York
$4.82M +$1.08M +27,095 +29%
Charles Schwab
41
Charles Schwab
California
$4.5M +$1.13M +28,306 +34%
Point72 Asset Management
42
Point72 Asset Management
Connecticut
$4.12M +$4.12M +103,000 New
GTC
43
Ghost Tree Capital
New York
$4M +$4M +100,000 New
SIM
44
Spark Investment Management
New York
$3.59M -$84K -2,100 -2%
Morgan Stanley
45
Morgan Stanley
New York
$3.59M -$193K -4,825 -5%
DCM
46
DAFNA Capital Management
California
$3.3M +$400K +10,000 +14%
TCIM
47
TIAA CREF Investment Management
New York
$2.54M +$232K +5,795 +10%
Alyeska Investment Group
48
Alyeska Investment Group
Illinois
$2.39M -$1.61M -40,254 -40%
NC
49
NBW Capital
Massachusetts
$2.37M -$9.04K -226 -0.4%
LCM
50
Laurion Capital Management
New York
$2M -$404K -10,100 -17%
1
2
3 4 5